BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Penicillamine

The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.

297+ PubMed studies analyzed · 16 RCTs · Evidence Score: 45.4

Research Domains

Penicillamine has been studied across 17 research domains including 🦴 Bone & Joint, 🫁 Liver & Detox, ✨ Skin & Hair, 🫘 Kidney, 🧠 Focus & Attention. The primary research focus is 🦴 Bone & Joint with 34% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Penicillamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

trolox
2 shared targets
Iproniazid
2 shared targets
Deamino
2 shared targets
Levallorphan
2 shared targets
Minocycline
2 shared targets
Methimazole
2 shared targets
Linezolid
2 shared targets
Naproxen
2 shared targets
Meloxicam
2 shared targets
Phenylbutazone
2 shared targets
Loading evidence profile...

This evidence profile for Penicillamine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.